NO972927L - 19-nor-progesteronderivater med 14<alfa>,17<beta>-C2-bro - Google Patents

19-nor-progesteronderivater med 14<alfa>,17<beta>-C2-bro

Info

Publication number
NO972927L
NO972927L NO972927A NO972927A NO972927L NO 972927 L NO972927 L NO 972927L NO 972927 A NO972927 A NO 972927A NO 972927 A NO972927 A NO 972927A NO 972927 L NO972927 L NO 972927L
Authority
NO
Norway
Prior art keywords
alfa
beta
bridge
progesterone derivatives
progesterone
Prior art date
Application number
NO972927A
Other languages
English (en)
Other versions
NO310198B1 (no
NO972927D0 (no
Inventor
Klaus Schoellkopf
Wolfgang Halfbrodt
Joachim Kuhnke
Wolfgang Schwede
Karl-Heinrich Fritzemeier
Rolf Krattenmacher
Hans-Peter Muhn
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO972927D0 publication Critical patent/NO972927D0/no
Publication of NO972927L publication Critical patent/NO972927L/no
Publication of NO310198B1 publication Critical patent/NO310198B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO19972927A 1994-12-23 1997-06-23 19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene NO310198B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447401A DE4447401A1 (de) 1994-12-23 1994-12-23 14,17-C¶2¶-überbrückte Steroide
PCT/EP1995/005107 WO1996020209A2 (de) 1994-12-23 1995-12-23 14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE

Publications (3)

Publication Number Publication Date
NO972927D0 NO972927D0 (no) 1997-06-23
NO972927L true NO972927L (no) 1997-08-22
NO310198B1 NO310198B1 (no) 2001-06-05

Family

ID=6537601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972927A NO310198B1 (no) 1994-12-23 1997-06-23 19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene

Country Status (33)

Country Link
US (3) US5827842A (no)
EP (1) EP0799238B1 (no)
JP (1) JPH10511379A (no)
KR (1) KR100400621B1 (no)
CN (1) CN1109689C (no)
AR (1) AR002263A1 (no)
AT (1) ATE193300T1 (no)
AU (1) AU692346B2 (no)
BG (1) BG63274B1 (no)
CA (1) CA2208605C (no)
CZ (1) CZ292696B6 (no)
DE (2) DE4447401A1 (no)
DK (1) DK0799238T3 (no)
EE (1) EE03356B1 (no)
ES (1) ES2151612T3 (no)
FI (1) FI972624A0 (no)
GR (1) GR3034261T3 (no)
HU (1) HUP0600457A2 (no)
IL (1) IL116504A (no)
LT (1) LT4295B (no)
LV (1) LV11954B (no)
NO (1) NO310198B1 (no)
NZ (1) NZ298770A (no)
PL (1) PL182642B1 (no)
PT (1) PT799238E (no)
RO (1) RO119366B1 (no)
RU (1) RU2169153C2 (no)
SI (1) SI9520137A (no)
SK (1) SK282281B6 (no)
TW (1) TW333536B (no)
UA (1) UA45382C2 (no)
WO (1) WO1996020209A2 (no)
ZA (1) ZA9510923B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3310301B2 (ja) * 1996-09-03 2002-08-05 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク ビタミンｄおよびステロイド誘導体の合成用中間体およびその製造方法
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
DE19848305C1 (de) * 1998-10-14 2000-05-25 Schering Ag Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
EP1216699A1 (de) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
CN100531738C (zh) * 2001-10-26 2009-08-26 欧加农股份有限公司 (11β,17β)-11-(1,3-苯并间二氧杂环戊烯-5-基)-17-羟基-17-(1-丙炔基)雌-4,9-二烯-3-酮在治疗重性抑郁症中的应用
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628189A1 (de) 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
GR3034261T3 (en) 2000-12-29
PL182642B1 (pl) 2002-02-28
CA2208605C (en) 2008-07-15
EP0799238A2 (de) 1997-10-08
LT97106A (en) 1997-10-27
WO1996020209A3 (de) 1996-09-06
UA45382C2 (uk) 2002-04-15
NO310198B1 (no) 2001-06-05
CN1171115A (zh) 1998-01-21
LT4295B (lt) 1998-02-25
ZA9510923B (en) 1996-07-04
AR002263A1 (es) 1998-03-11
IL116504A0 (en) 1996-03-31
SK78897A3 (en) 1997-12-10
PL320799A1 (en) 1997-10-27
EP0799238B1 (de) 2000-05-24
ATE193300T1 (de) 2000-06-15
DE59508403D1 (de) 2000-06-29
DK0799238T3 (da) 2000-10-09
SK282281B6 (sk) 2002-01-07
TW333536B (en) 1998-06-11
IL116504A (en) 2001-11-25
BG101554A (en) 1998-09-30
LV11954A (lv) 1998-01-20
AU692346B2 (en) 1998-06-04
CN1109689C (zh) 2003-05-28
US6147065A (en) 2000-11-14
US5827842A (en) 1998-10-27
WO1996020209A2 (de) 1996-07-04
KR100400621B1 (ko) 2004-02-05
LV11954B (lv) 1998-06-20
ES2151612T3 (es) 2001-01-01
FI972624A7 (fi) 1997-06-18
RU2169153C2 (ru) 2001-06-20
SI9520137A (sl) 1998-02-28
BG63274B1 (bg) 2001-08-31
MX9704774A (es) 1997-10-31
NO972927D0 (no) 1997-06-23
AU4433896A (en) 1996-07-19
FI972624A0 (fi) 1997-06-18
RO119366B1 (ro) 2004-08-30
CA2208605A1 (en) 1996-07-04
CZ195497A3 (cs) 1998-03-18
DE4447401A1 (de) 1996-07-04
HUP0600457A2 (en) 2006-08-28
CZ292696B6 (cs) 2003-11-12
PT799238E (pt) 2000-11-30
EE03356B1 (et) 2001-02-15
US5973172A (en) 1999-10-26
NZ298770A (en) 1999-10-28
JPH10511379A (ja) 1998-11-04

Similar Documents

Publication Publication Date Title
NO920137L (no) Blindnaglemutter med trekkdor
NL300150I2 (nl) 4 &#34;-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
FI924389L (fi) Finfoerdelade, absorberande polymerkompositioner innehaollande aggregat med inboerdes tvaerbundna partiklar
DE59510955D1 (de) Offsetdruckmaschine
BR9508318A (pt) Composição impadora concentrada
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
DE69528197D1 (de) Neue 1,3-dialkylharnstoff-derivate
IS5402A (is) Útskiptar króman afleiður
NO982473L (no) 5&#39;-Deoksy-cytidin derivater
DK1027361T3 (da) Derivater af erythromycin med 6,11-bro
DE69716901D1 (de) 2,4-diaminopyrimidin-derivate
NO20013013D0 (no) &lt;alfa&gt;v&lt;beta&gt;6-integrininhibitorer
NO971248D0 (no) 5&lt;alfa&gt;-reduktaseinhibitorer
IS5403A (is) Útskiptar króman afleiður
NO893524L (no) Piperazindioner med psykotrop virkning.
DE69503614D1 (de) Supraleitender übergang
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
FI912127A7 (fi) Effektivt delar utnyttjande, minnesbaserad funktionskrets med väljbara transmissionsegenskaper
NO972927D0 (no) 14&lt;alfa&gt;,17&lt;alfa&gt;-C2-broede 19-nor-progesteronderivater
DE69519515D1 (de) Selbstaufzeichnendes transferband
FI933107L (fi) Bastextilmaterial foer mellanfoder laempat foer smaeltbondning, omfattandevaeft texturerd med luftstraole
FI920834L (fi) Med fukos maerkta cytostater
ES1027890Y (es) Pieza ceramica perfeccionada.
FI954132A7 (fi) Diastrofisen dysplasian geeni